Dated saved text. This source is available for reading; it is not presented as current law.
Source details
- NYCRR title agency
- Executive Department
- Section status
- Dated saved text
- Effective date
- Mar 22, 2023
- Source version current through
- Jul 31, 2022
- Text saved
- Jun 6, 2026
- Publisher current-through date
- Jul 31, 2022
- Source captured
- Sep 13, 2026
- Stored text comparison
- Matches the captured source text
- Latest State Register issue indexed
- September 30, 2026 (Vol. XLVIII, Issue 39)
- Related Register notice
- OCM-24-22-00014-A · Adopted rule
- Related notice published
- Mar 22, 2023
- Related notice effective date
- Mar 22, 2023
Official change receipt OCM-24-22-00014-A
Unofficial text saved June 6, 2026. Related State Register notice: [notice](https://dos.ny.gov/system/files/documents/2023/03/032223.pdf). Related notice dates: published March 22, 2023; notice effective date March 22, 2023. The effect of the related notice on this saved text has not been confirmed.
(a)No person shall be a cannabis laboratory authorized to test medical cannabis and adult-use cannabis and issue laboratory test reports required by the Cannabis Law unless they have been granted a cannabis laboratory permit. A laboratory certified by the New York State Department of Health to conduct medical cannabis testing shall be deemed a provisional permittee and must comply with this Part.
(b)
(1)An application for a cannabis laboratory permit shall be submitted to the office in a manner and format determined by the board. The application shall be signed by technical directors of a cannabis laboratory, and the following individuals:
(i)by the applicant (if an individual);
(ii)by a managing member (if a limited liability company);
(iii)by an officer (if a corporation);
(iv)by all partners (if a partnership); or
(v)by an officer, director or trustee if an institution, trust, estate, or any other legal entity.
(2)At the time of application for a cannabis laboratory permit, the Board may require information regarding a cannabis laboratory, including, but not limited to:
(i)proof of ISO/IEC 17025 accreditation;
(ii)ownership, true parties of interest, financiers, organization structure;
(iii)quality control systems;
(iv)proficiency testing program;
(v)the premises;
(vi)qualification of personnel;
(vii)training programs;
(viii)consumables including but not limited to reagents and standard reference materials;
(ix)laboratory equipment;
(x)method of reporting results; and
(xi)any other information as requested by the Office.
(3)An application for a cannabis laboratory permit under this Part shall be accompanied by a non-refundable application fee in the amount of $1,000. Prior to issuance or renewal of a permit, an application or renewal application fee of $1,000, and permit fee shall be paid, unless otherwise expressly authorized by the Board pursuant to this Part.
(4)For an analyte or group of analytes which the Office requires testing, an application for a cannabis laboratory permit shall specify an analyte or group of analytes that a cannabis laboratory is seeking approval for, the cannabis product or medical cannabis and any other intermediates or forms to be analyzed, and the approved methods to be employed for an analyte or group of analytes in cannabis product or medical cannabis, and any other intermediates or forms.